Literature DB >> 30904819

Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.

Samuel McLenachan1, Elaine Y M Wong2, Xiao Zhang1, Fiona Leith3, Sang Yoon Moon4, Dan Zhang5, Shang-Chih Chen5, Jennifer A Thompson6, Terri McLaren7, Tina Lamey7, John N De Roach7, Marcus D Atlas8, Rodney J Dilley9, Fred K Chen10.   

Abstract

The human iPSC lines LEIi010-A and LEIi010-B were generated from the dermal fibroblasts of a patient with Usher syndrome using episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, mir302/367 microRNA and shRNA for p53. These iPSC lines carry compound heterozygous mutations (c.949C > A and c.1256G > T) in USH2A. LEIi010-A and LEIi010-B expressed pluripotent stem cell markers, had a normal karyotype and could be differentiated into endoderm, mesoderm and ectodermal lineages.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30904819     DOI: 10.1016/j.scr.2019.101420

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  1 in total

1.  Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells.

Authors:  Xuezhong Liu; Justin Lillywhite; Wenliang Zhu; Zaohua Huang; Anna M Clark; Nicholas Gosstola; Colin T Maguire; Derek Dykxhoorn; Zheng-Yi Chen; Jun Yang
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.